Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis

Bianca van den Berg(Erasmus MC), Christa Walgaard(Erasmus MC), Judith Drenthen(Erasmus MC), C. Fokke(Gelre Hospitals), Bart C. Jacobs(Erasmus MC), Pieter A. van Doorn(Erasmus MC)
Nature Reviews Neurology
July 15, 2014
10.1038/nrneurol.2014.121
Cited by 1,071Open Access
Full Text

Abstract

Related Papers

Intravenous immunoglobulin for Guillain-Barré syndrome
Richard AC Hughes, A V Swan, Pieter A. van Doorn|Cochrane Database of Systematic Reviews|2014|711
The glycosynapse
Sen‐itiroh Hakomori|Proceedings of the National Academy of Sciences|2002|491
Plasma exchange for Guillain-Barré syndrome
Jean Claude Raphaël, Sylvie Chevret, Richard AC Hughes et al.|Cochrane Database of Systematic Reviews|2002|413
Prediction of respiratory insufficiency in Guillain‐Barré syndrome
Christa Walgaard, Hester F. Lingsma, Liselotte Ruts et al.|Annals of Neurology|2010|318
IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndrome
Satoshi Kuwabara, Nobuhiro Yuki, Michiaki Koga et al.|Annals of Neurology|1998|308